NCT03773380View on ClinicalTrials.gov

Breathe Anew for Lung Cancer Survivorship

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Lung Cancer
Interventions
COMBINATION_PRODUCT

Breathe Anew Survivorship Program

The feasibility will be tested of the Breathe Anew Survivorship Program

Trial Locations (1)

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

All Listed Sponsors
lead

St. Joseph's Healthcare Hamilton

OTHER

NCT03773380 - Breathe Anew for Lung Cancer Survivorship | Biotech Hunter | Biotech Hunter